Foresite Capital Management IV’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-49,600	Closed	-$1.42M	–	19
2018 Q3	$1.42M	Buy	+49,600	New	+$1.42M	0.47%	19